StockData
Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd (RDY) stock

RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.79+0.09 (+0.61%)

Close on Nov 17, 2026Market cap $12.34BP/E 27.1Yield 0.57%

Dr Reddys Laboratories pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Dr Reddys Laboratories's pe ratio was 27.1× on Nov 11, 2026, against 18.5× a year earlier. Over the last 5 years it ranged from 16.7× to 46.9×, with a median of 21.4×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202627.1×+8.5
2025Dec 31, 202518.6×−1.6
2024Dec 31, 202420.2×−1.1
2023Dec 29, 202321.4×−8.8
2022Dec 30, 202230.2×−16.7
2021Dec 31, 202146.9×+2.6
2020Dec 31, 202044.3×+18.7
2019Dec 31, 201925.6×−18.9
2018Dec 31, 201844.5×+11.2
2017Dec 29, 201733.3×+7.0
2016Dec 30, 201626.3×–

More Dr Reddys Laboratories figures

See a number that looks wrong?